|
|
Study on quality standard of Sanghuang of North Korea medicine |
WANG Hui1 WANG Yue-qi2 YANG Shu-dong3▲ HAN Da4 SONG Ai-qun4 |
1.Room of Traditional Chinese Medicine,Changchun Institute for Food and Drug Control,Jilin Province,Changchun 130012,China;
2.Faculty of Chemistry,Northeast Normal University,Jilin Province,Changchun 130024,China;
3.Department of Analysis Instrument and Study,Changchun Institute for Food and Drug Control,Jilin Province,Changchun 130012,China;
4.Department of Project Management,Jilin Province Tonghua Boxiang Pharmaceutical Co.Ltd.,Jilin Province,Ji′an 134200,China |
|
|
Abstract Objective To establish the quality standard for Sanghuang of North Korea medicine.Methods Microwave digestion-inductively coupled plasma mass spectrometry(ICP-MS)was used to determine the content of 26 elements in Sanghuang,thin layer chromatography(TLC)was used to identify Sanghuang,the content of Sanghuang′s polysaccharide and total flavonoids were determined by ultraviolet-visible spectrophotometry.Results The r value of standard curve,recovery rate and relative standard deviation(n=6)of 26 elements by ICP-MS met the requirements of Pharmacopoeia of the People′s Republic of China(2020,Volume Ⅳ).The five high content beneficial elements in 10 batches of Sanghuang from different areas were kalium(2772.0-6514.7 mg/kg),magnesium(1299.9-1938.2 mg/kg),calcium(523.62-1753.90 mg/kg),sodium(19.886-359.370 mg/kg)and iron(38.469-534.440 mg/kg).The TLC method was effective in the identification of Sanghuang.There were a good linear relationship of Sanghuang′s polysaccharide in the range of 0.024-0.120 mg(r=0.9982)and the total flavonoids of total flavonoids in the range of 0.2-1.2 mg(r=0.9996).Conclusion According to the Pharmacopoeia of the People′s Republic of China(2020,Volume Ⅰ),the content of five heavy metals and harmful elements in 10 batches of Sanghuang from different places do meet regulations;five high content beneficial elements may be related to the efficacy of Sanghuang;the other 16 low content elements have no safety risk so far.Ten batches of samples from different places are investigated.The established standard can effectively control the quality,which is of great significance to its research and development.
|
|
|
|
|
[1] |
包海鹰,李玉.中国菌物药[M].郑州:中原农民出版社,2021:26-34.
|
[2] |
南京中医药大学.中药大辞典[M].上海:上海科学技术出版社,2006:2784.
|
[3] |
朴明杰.乡药集成方[M].延边:延边人民出版社,2005:230.
|
[4] |
郑飞,孟歌,安琪,等.药用真菌桑黄液体培养过程中的抗氧化活性研究[J].菌物学报,2017,36(1):98-111.
|
[5] |
孙佳琦,张甘霖,于明巍,等.桑黄成分及其抗肿瘤作用机制研究进展[J].中国医药导报,2016,13(33):39-47.
|
[6] |
史帧婷,包海鹰.桑黄成分及其抗肿瘤作用机制研究进展[J].中国医药导报,2016,13(33):39-47.
|
[7] |
吴声华,戴玉成.药用真菌桑黄的种类解析[J].菌物学报,2020,39(5):781-794.
|
[8] |
湖北省食品药品监督管理局.湖北省中药材标准(2009 版)[M].武汉:湖北科学技术出版社,2009:113.
|
[9] |
YCBZ2020-048.桑黄[S].兰州:甘肃省药品监督管理局,2020.
|
[10] |
安徽省药品监督管理局.安徽省中药饮片炮制规范(第三版)(2019年)[M].合肥:安徽科学技术出版社,2019:252.
|
[11] |
吉林省药品监督管理局.吉林省中药材标准(第二册)2019年版[M].长春:吉林科学技术出版社,2020:34.
|
[12] |
吉林省药品监督管理局.吉林省中药饮片炮制规范(第一册)2020年版[M].长春:吉林科学技术出版社,2020:180.
|
[13] |
国家药典委员会.中华人民共和国药典四部(2020年版)[M].北京:中国医药科技出版社,2020:59,482.
|
[14] |
国家药典委员会.中华人民共和国药典一部(2020年版)[M].北京:中国医药科技出版社,2020:195,8.
|
[15] |
许磊.常用跌打损伤中药中钾元素的含量测定与研究[D].太原:山西大学,2012:9-12.
|
[16] |
因杰秀.归心经中草药中钾、钙、钠、镁含量测定与研究[D].太原:山西大学,2010:1-46.
|
[17] |
王晋昆,曹晶晶,张永昌.锑对人体健康影响研究进展[J].职业卫生与应急救援,2019,37(6):601-604.
|
[18] |
韩嘉艺,叶必雄,张振伟,等.生活饮用水铊短期超标的风险评估探讨[J].现代预防医学,2021,48(5):944-947.
|
[19] |
郭廷敏,王娟,张哲,等.一起碳酸钡引起食物中毒的调查与分析[J].中国卫生检验杂志,2018,28(24):3036-3039.
|
[20] |
李东东,刘海燕,宿抱玉,等.桑黄多糖对肿瘤微环境影响的研究[J].泰山医学院学报,2020,41(4):318-320.
|
[21] |
穆鹏.桑黄多糖改善有氧运动机能的有效性分析[J].中国食用菌,2020,39(7):201-203.
|
[22] |
严红实,金乾坤,李鹏飞,等.桑黄多糖的提取及抗氧化性研究[J].食品科技,2013,38(6):201-205.
|
[23] |
王中喜,王晓娟,田玉菊.桑黄多糖对小鼠骨髓造血机能损伤的保护作用[J].长春中医药大学学报,2006,22(2):67.
|
[24] |
李善姬,梁承武,崔承弼,等.野生桑黄总黄酮提取工艺及其抗氧化作用的研究[J].食品研究与开发,2015,36(20):32-35.
|
[25] |
回晶,李其久,边媛媛,等.桑黄总黄酮超声提取工艺及其生物活性研究[J].食品科学,2010,31(24):195-198.
|
|
|
|